Botanical ingredients like ashwagandha are facing growing scrutiny in Europe, often fueled by misinformation and outdated myths. Despite centuries of safe use, these ancient botanicals are now subject to misplaced concerns.
To bring clarity to the conversation, the Kerry Health and Nutrition Institute (KHNI) has launched a new podcast series, KHNI Talks. In the first episode, scientific experts take a deep dive into the evidence surrounding ashwagandha, separating fact from fiction.
Host Brian Short is joined by Dr. Thomas Brendler, founder of Plantifile and Guest Editor of a special series of papers on ashwagandha in Phytotherapy Research, and Dr. Mukesh Summan, former FDA toxicologist and current Global Director of Toxicology, at Kerry. Together, they explore the latest scientific data and regulatory perspectives to help listeners better understand the safety and efficacy of this widely used botanical.
